Low-Dose Maraviroc, an Antiretroviral Drug, Attenuates the Infiltration of T Cells into the Central Nervous System and Protects the Nigrostriatum in Hemiparkinsonian Monkeys.

Low-Dose Maraviroc, an Antiretroviral Drug, Attenuates the Infiltration of T Cells into the Central Nervous System and Protects the Nigrostriatum in Hemiparkinsonian Monkeys.
Related ArticlesLow-Dose Maraviroc, an Antiretroviral Drug, Attenuates the Infiltration of T Cells into the Central Nervous System and Protects the Nigrostriatum in Hemiparkinsonian Monkeys. J Immunol. 2019 May 01;: Authors: Mondal S, Rangasamy SB, Roy A, Dasarathy S, Kordower JH, Pahan K Abstract Parkinson disease (PD) is the most common neurodegenerative movement disorder in humans. Despite intense investigation, no effective ... read more
Source: PubMedPublished on 2019-05-03